Laurent Azoulay (L Azoulay)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 70

Top Topics

Angiotensin Converting Enzyme

Benign Prostatic Hyperplasia

Clinical Practice

Top Venues

BMJ (Clinical research ed.)

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Niamh Doherty, Chris Cardwell, Peter Murchie, Christopher Hill, Laurent Azoulay, Blánaid M Hicks
Use of 5-alpha reductase inhibitors and risk of gastrointestinal cancers in men with benign prostatic hyperplasia: A population-based cohort study. International journal of cancer 155 (4) (2024)
Nikita Simms-Williams, Nir Treves, Hui Yin, Sally Lu, Oriana Yu, Richeek Pradhan, Christel Renoux, Samy Suissa, Laurent Azoulay
Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study. BMJ (Clinical research ed.) 385 (2024)
Ruth Sapir-Pichhadze, Claudie Laprise, Marie-Eve Beauchamp, Mohammed Kaouache, Xun Zhang, Alexia Della Vecchia, Laurent Azoulay, Eduardo L Franco, Michal Abrahamowicz, Belinda Nicolau
Immunosuppression and cancer risk in kidney transplant recipients: A retrospective cohort study. International journal of cancer (2024)
Ruth Sapir-Pichhadze, Claudie Laprise, Marie-Eve Beauchamp, Mohammed Kaouache, Xun Zhang, Alexia Della Vecchia, Laurent Azoulay, Eduardo L Franco, Michal Abrahamowicz, Belinda Nicolau
Immunosuppression and cancer risk in kidney transplant recipients: A retrospective cohort study. International journal of cancer 154 (12) (2024)
Samantha B Shapiro, Hui Yin, Oriana H Y Yu, Laurent Azoulay
Dipeptidyl Peptidase-4 Inhibitors and the Risk of Gallbladder and Bile Duct Disease Among Patients with Type 2 Diabetes: A Population-Based Cohort Study. Drug safety (2024)
Samantha B Shapiro, Hui Yin, Oriana H Y Yu, Laurent Azoulay
Dipeptidyl Peptidase-4 Inhibitors and the Risk of Gallbladder and Bile Duct Disease Among Patients with Type 2 Diabetes: A Population-Based Cohort Study. Drug safety 47 (8) (2024)
Ruth Sapir-Pichhadze, Claudie Laprise, Marie-Eve Beauchamp, Mohammed Kaouache, Xun Zhang, Alexia Della Vecchia, Laurent Azoulay, Eduardo L Franco, Michal Abrahamowicz, Belinda Nicolau
Immunosuppression and cancer risk in kidney transplant recipients: A retrospective cohort study. International journal of cancer 154 (12) (2024)
Niamh Doherty, Chris Cardwell, Peter Murchie, Christopher Hill, Laurent Azoulay, Blánaid M Hicks
Use of 5-alpha reductase inhibitors and risk of gastrointestinal cancers in men with benign prostatic hyperplasia: A population-based cohort study. International journal of cancer (2024)
Nikita Simms-Williams, Nir Treves, Hui Yin, Sally Lu, Oriana Yu, Richeek Pradhan, Christel Renoux, Samy Suissa, Laurent Azoulay
Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study. BMJ (Clinical research ed.) 385 (2024)
Samantha B Shapiro, Hui Yin, Oriana H Y Yu, Laurent Azoulay
Sodium-glucose cotransporter-2 inhibitors and the risk of lung cancer among patients with type 2 diabetes. British journal of clinical pharmacology 90 (5) (2024)
Nikita Simms-Williams, Nir Treves, Hui Yin, Sally Lu, Oriana Yu, Richeek Pradhan, Christel Renoux, Samy Suissa, Laurent Azoulay
Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study. BMJ (Clinical research ed.) 385 (2024)
Nikita Simms-Williams, Nir Treves, Hui Yin, Sally Lu, Oriana Yu, Richeek Pradhan, Christel Renoux, Samy Suissa, Laurent Azoulay
Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study. BMJ (Clinical research ed.) 385 (2024)
Nikita Simms-Williams, Nir Treves, Hui Yin, Sally Lu, Oriana Yu, Richeek Pradhan, Christel Renoux, Samy Suissa, Laurent Azoulay
Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study. BMJ (Clinical research ed.) 385 (2024)
Samantha B Shapiro, Hui Yin, Oriana H Y Yu, Laurent Azoulay
Sodium-glucose cotransporter-2 inhibitors and the risk of lung cancer among patients with type 2 diabetes. British journal of clinical pharmacology (2024)
Samantha B Shapiro, Hui Yin, Oriana H Y Yu, Laurent Azoulay
Sodium-glucose cotransporter-2 inhibitors and the risk of lung cancer among patients with type 2 diabetes. British journal of clinical pharmacology 90 (5) (2024)
Nikita Simms-Williams, Nir Treves, Hui Yin, Sally Lu, Oriana Yu, Richeek Pradhan, Christel Renoux, Samy Suissa, Laurent Azoulay
Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study. BMJ (Clinical research ed.) 385 (2024)
Niamh Doherty, Christopher R Cardwell, Peter Murchie, Christopher Hill, Laurent Azoulay, Blánaid M Hicks
5-Alpha Reductase Inhibitors and Risk of Kidney and Bladder Cancers in Men with Benign Prostatic Hyperplasia: A Population-Based Cohort Study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2023)
Richeek Pradhan, Oriana H Y Yu, Robert W Platt, Laurent Azoulay
Dipeptidyl peptidase-4 inhibitors and the risk of skin cancer among patients with type 2 diabetes: a UK population-based cohort study. BMJ open diabetes research & care 11 (6) (2023)
Devin Abrahami, Richeek Pradhan, Hui Yin, Russell Yanofsky, Emily Gibson McDonald, Alain Bitton, Laurent Azoulay
Proton pump inhibitors and the risk of inflammatory bowel disease: population-based cohort study. Gut (2023)
Niamh Doherty, Christopher R Cardwell, Peter Murchie, Christopher Hill, Laurent Azoulay, Blánaid M Hicks
5α-Reductase Inhibitors and Risk of Kidney and Bladder Cancers in Men with Benign Prostatic Hyperplasia: A Population-Based Cohort Study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 32 (3) (2023)
Niamh Doherty, Christopher R Cardwell, Peter Murchie, Christopher Hill, Laurent Azoulay, Blánaid M Hicks
5α-Reductase Inhibitors and Risk of Kidney and Bladder Cancers in Men with Benign Prostatic Hyperplasia: A Population-Based Cohort Study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 32 (3) (2023)
Niamh Doherty, Christopher R Cardwell, Peter Murchie, Christopher Hill, Laurent Azoulay, Blánaid M Hicks
5-Alpha Reductase Inhibitors and Risk of Kidney and Bladder Cancers in Men with Benign Prostatic Hyperplasia: A Population-Based Cohort Study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2023)
Richeek Pradhan, Oriana H Y Yu, Robert W Platt, Laurent Azoulay
Glucagon Like Peptide-1 Receptor Agonists and the Risk of Skin Cancer Among Patients with Type 2 Diabetes: Population-Based Cohort Study. Diabetic medicine : a journal of the British Diabetic Association (2023)
Devin Abrahami, Elvira D'Andrea, Hui Yin, Seoyoung C Kim, Julie M Paik, Deborah Wexler, Laurent Azoulay, Elisabetta Patorno
Contemporary trends in the utilization of second-line pharmacological therapies for type 2 diabetes in the United States and the United Kingdom. Diabetes, obesity & metabolism (2023)
Niamh Doherty, Christopher R Cardwell, Peter Murchie, Christopher Hill, Laurent Azoulay, Blánaid M Hicks
5α-Reductase Inhibitors and Risk of Kidney and Bladder Cancers in Men with Benign Prostatic Hyperplasia: A Population-Based Cohort Study. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 32 (3) (2023)
Krishna Roy Chowdhury, Jonathan Michaud, Oriana Hoi Yun Yu, Hui Yin, Laurent Azoulay, Christel Renoux
Effectiveness and Safety of Apixaban versus Rivaroxaban in Patients with Atrial Fibrillation and Type 2 Diabetes Mellitus. Thrombosis and haemostasis 122 (10) (2022)
Richeek Pradhan, Hui Yin, Oriana Yu, Laurent Azoulay
Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Nonalcoholic Fatty Liver Disease Among Patients With Type 2 Diabetes. Diabetes care 45 (4) (2022)
Julie Rouette, Emily Gibson McDonald, Tibor Schuster, James M Brophy, Laurent Azoulay
Dihydropyridine Calcium Channel Blockers and Risk of Pancreatic Cancer: A Population-Based Cohort Study. Journal of the American Heart Association 11 (24) (2022)
Julie Rouette, Emily Gibson McDonald, Tibor Schuster, James M Brophy, Laurent Azoulay
Dihydropyridine Calcium Channel Blockers and Risk of Pancreatic Cancer: A Population-Based Cohort Study. Journal of the American Heart Association 11 (24) (2022)
Julie Rouette, Emily G McDonald, Tibor Schuster, James M Brophy, Laurent Azoulay
Treatment and prescribing trends of antihypertensive drugs in 2.7 million UK primary care patients over 31 years: a population-based cohort study. BMJ open 12 (6) (2022)
Richeek Pradhan, Sally Lu, Hui Yin, Oriana H Y Yu, Pierre Ernst, Samy Suissa, Laurent Azoulay
Novel antihyperglycaemic drugs and prevention of chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes: population based cohort study. BMJ (Clinical research ed.) 379 (2022)
Farzin Khosrow-Khavar, Laurent Azoulay, Jean-Louis Montastruc, François Montastruc, Christel Renoux
Aromatase inhibitors and the incidence of Parkinson disease: A population-based cohort study. Cancer 128 (12) (2022)
Laurent Azoulay
Rationale, Strengths, and Limitations of Real-World Evidence in Oncology: A Canadian Review and Perspective. The oncologist 27 (9) (2022)
Richeek Pradhan, Hui Yin, Oriana H Y Yu, Laurent Azoulay
Incretin-Based Drugs and the Risk of Acute Liver Injury Among Patients With Type 2 Diabetes. Diabetes care 45 (10) (2022)
Julie Rouette, Emily Gibson McDonald, Tibor Schuster, James M Brophy, Laurent Azoulay
Dihydropyridine Calcium Channel Blockers and Risk of Pancreatic Cancer: A Population-Based Cohort Study. Journal of the American Heart Association (2022)
Julie Rouette, Emily Gibson McDonald, Tibor Schuster, James M Brophy, Laurent Azoulay
Dihydropyridine Calcium Channel Blockers and Risk of Pancreatic Cancer: A Population-Based Cohort Study. Journal of the American Heart Association 11 (24) (2022)
Devin Abrahami, Helen Tesfaye, Hui Yin, Seanna Vine, Blánaid Hicks, Oriana H Y Yu, Lysanne Campeau, Robert W Platt, Sebastian Schneeweiss, Elisabetta Patorno, Laurent Azoulay
Sodium-Glucose Cotransporter 2 Inhibitors and the Short-term Risk of Bladder Cancer: An International Multisite Cohort Study. Diabetes care 45 (12) (2022)
Anuradhaa Subramanian, Ji Eun Diana Han, Tasanee Braithwaite, Rasiah Thayakaran, Dawit T Zemedikun, Krishna M Gokhale, Wen Hwa Lee, Jesse Coker, Pearse A Keane, Alastair K Denniston, Krishnarajah Nirantharakumar, Laurent Azoulay, Nicola Jaime Adderley
Angiotensin-converting enzyme inhibitors and risk of age-related macular degeneration in individuals with hypertension. British journal of clinical pharmacology 88 (9) (2022)
Devin Abrahami, Laurent Azoulay
Response by Abrahami et al to letter regarding article 'Proton pump inhibitors and risk of colorectal cancer'. Gut (2021)
Linda B Ou, Laurent Azoulay, Pauline Reynier, Robert W Platt, Sarah Yoon, Roland Grad, Kristian B Filion
Tramadol versus codeine and the short-term risk of cardiovascular events in patients with non-cancer pain: A population-based cohort study. British journal of clinical pharmacology (2021)
Vanessa C Brunetti, Pauline Reynier, Laurent Azoulay, Oriana Hoi Yun Yu, Pierre Ernst, Robert W Platt, Kristian B Filion
SGLT-2 inhibitors and the risk of hospitalization for community-acquired pneumonia: A population-based cohort study. Pharmacoepidemiology and drug safety 30 (6) (2021)
Jean-Luc Faillie, Hui Yin, Oriana H Y Yu, Astrid Herrero, Romain Altwegg, Christel Renoux, Laurent Azoulay
Incretin-Based Drugs and Risk of Intestinal Obstruction Among Patients With Type 2 Diabetes. Clinical pharmacology and therapeutics (2021)
Balachandran Kumarendran, Michael W O'Reilly, Anuradhaa Subramanian, Dana Šumilo, Konstantinos Toulis, Krishna M Gokhale, Chandrika N Wijeratne, Arri Coomarasamy, Abd A Tahrani, Laurent Azoulay, Wiebke Arlt, Krishnarajah Nirantharakumar
Polycystic Ovary Syndrome, Combined Oral Contraceptives, and the Risk of Dysglycemia: A Population-Based Cohort Study With a Nested Pharmacoepidemiological Case-Control Study. Diabetes care 44 (12) (2021)
Lisa K Kuramoto, Boris G Sobolev, Jan Rosner, Penelope M A Brasher, Laurent Azoulay, Jacquelyn J Cragg
A systematic, concept-based method of developing the exposure measure for drug safety and effectiveness studies. Pharmacoepidemiology and drug safety (2021)
Seoyoung C Kim, Sebastian Schneeweiss, Antonios Douros, Kristian B Filion, Hui Yin, Elisabetta Patorno, Laurent Azoulay
The modifying effects of adiposity on the cardiovascular safety of sulphonylureas. Diabetes, obesity & metabolism 23 (11) (2021)
Devin Abrahami, Emily Gibson McDonald, Mireille E Schnitzer, Alan N Barkun, Samy Suissa, Laurent Azoulay
Proton pump inhibitors and risk of colorectal cancer. Gut 71 (1) (2021)
Julie Rouette, Hui Yin, Emily G McDonald, Alan Barkun, Laurent Azoulay
Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Acute Pancreatitis: A Population-Based Cohort Study. Drug safety (2021)
Devin Abrahami, Emily Gibson McDonald, Mireille E Schnitzer, Alan N Barkun, Samy Suissa, Laurent Azoulay
Proton pump inhibitors and risk of gastric cancer: population-based cohort study. Gut 71 (1) (2021)
Devin Abrahami, Christel Renoux, Hui Yin, Jean-Pascal Fournier, Laurent Azoulay
The Association between Oral Anticoagulants and Cancer Incidence among Individuals with Nonvalvular Atrial Fibrillation. Thrombosis and haemostasis 120 (10) (2020)
J Rouette, H Yin, O H Y Yu, N Bouganim, R W Platt, Laurent Azoulay
Incretin-based drugs and risk of lung cancer among individuals with type 2 diabetes. Diabetic medicine : a journal of the British Diabetic Association 37 (5) (2020)
Devin Abrahami, Emily Gibson McDonald, Mireille Schnitzer, Laurent Azoulay
Trends in acid suppressant drug prescriptions in primary care in the UK: a population-based cross-sectional study. BMJ open 10 (12) (2020)
E Ripamonti, Laurent Azoulay, M Abrahamowicz, R W Platt, S Suissa
Pioglitazone and bladder cancer: improving research methods. Diabetic medicine : a journal of the British Diabetic Association 37 (5) (2020)
Devin Abrahami, Richeek Pradhan, Hui Yin, Peter Honig, Elodie Baumfeld Andre, Laurent Azoulay
Use of Real-World Data to Emulate a Clinical Trial and Support Regulatory Decision Making: Assessing the Impact of Temporality, Comparator Choice, and Method of Adjustment. Clinical pharmacology and therapeutics 109 (2) (2020)
Richeek Pradhan, Hui Yin, Oriana H Y Yu, Laurent Azoulay
The Use of Long-Acting Insulin Analogs and the Risk of Colorectal Cancer Among Patients with Type 2 Diabetes: A Population-Based Cohort Study. Drug safety 43 (2) (2020)
Giovanni Giorli, Julie Rouette, Hui Yin, Francesco Lapi, Monica Simonetti, Claudio Cricelli, Michael Pollak, Laurent Azoulay
Prediagnostic use of low-dose aspirin and risk of incident metastasis and all-cause mortality among patients with colorectal cancer. British journal of clinical pharmacology 86 (11) (2020)
Melanie Suissa, Hui Yin, Oriana H Y Yu, Stephanie M Wong, Laurent Azoulay
Sodium-Glucose Cotransporter 2 Inhibitors and the Short-term Risk of Breast Cancer Among Women With Type 2 Diabetes. Diabetes care 44 (1) (2020)
Julie Rouette, Hui Yin, Anton Pottegård, Krishnarajah Nirantharakumar, Laurent Azoulay
Use of Hydrochlorothiazide and Risk of Melanoma and Nonmelanoma Skin Cancer. Drug safety 44 (2) (2020)
Henok Tadesse Ayele, Pauline Reynier, Laurent Azoulay, Robert W Platt, Josselin Cabaussel, Serge Benayoun, Kristian B Filion
Trends in the pharmacological treatment of benign prostatic hyperplasia in the UK from 1998 to 2016: a population-based cohort study. World journal of urology 39 (6) (2020)
Matthew H Secrest, Laurent Azoulay, Matthew Dahl, Kristin K Clemens, Madeleine Durand, Nianping Hu, Laura Targownik, Tanvir C Turin, Colin R Dormuth, Kristian B Filion
A population-based analysis of antidiabetic medications in four Canadian provinces: Secular trends and prescribing patterns. Pharmacoepidemiology and drug safety (2019)
Antonios Douros, Julie Rouette, Hui Yin, Oriana Hoi Yun Yu, Kristian B Filion, Laurent Azoulay
Dipeptidyl Peptidase 4 Inhibitors and the Risk of Bullous Pemphigoid Among Patients With Type 2 Diabetes. Diabetes care 42 (8) (2019)
Kristian B Filion, Antonios Douros, Laurent Azoulay, Hui Yin, Oriana H Yu, Samy Suissa
Sulfonylureas as initial treatment for type 2 diabetes and the risk of adverse cardiovascular events: A population-based cohort study. British journal of clinical pharmacology 85 (10) (2019)
Devin Abrahami, Antonios Douros, Hui Yin, Oriana H Y Yu, Laurent Azoulay
Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Fractures Among Patients With Type 2 Diabetes. Diabetes care 42 (9) (2019)
Elodie Baumfeld Andre, Robert Reynolds, Patrick Caubel, Laurent Azoulay, Nancy A Dreyer
Trial designs using real-world data: The changing landscape of the regulatory approval process. Pharmacoepidemiology and drug safety 29 (10) (2019)
Jennifer W Wu, Laurent Azoulay, Anjie Huang, Michael Paterson, Fangyun Wu, Matthew H Secrest, Kristian B Filion
Identification of incident pancreatic cancer in Ontario administrative health data: A validation study. Pharmacoepidemiology and drug safety (2018)
Devin Abrahami, Antonios Douros, Hui Yin, Oriana Hy Yu, Jean-Luc Faillie, François Montastruc, Robert W Platt, Nathaniel Bouganim, Laurent Azoulay
Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study. BMJ (Clinical research ed.) 363 (2018)
Blánaid M Hicks, Kristian B Filion, Hui Yin, Lama Sakr, Jacob A Udell, Laurent Azoulay
Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study. BMJ (Clinical research ed.) 363 (2018)
Adi J Klil-Drori, Hui Yin, Laurent Azoulay, Alexa Del Corpo, Michaël Harnois, Michel-Olivier Gratton, Harold J Olney, Robert Delage, Pierre Laneuville, Luigina Mollica, Lambert Busque, Sarit E Assouline, null null
Molecular monitoring of therapeutic milestones and clinical outcomes in patients with chronic myeloid leukemia. Cancer 125 (4) (2018)
Antonios Douros, Kristian B Filion, Hui Yin, Oriana Hoi Yu, Mahyar Etminan, Jacob A Udell, Laurent Azoulay
Glucagon-Like Peptide 1 Receptor Agonists and the Risk of Incident Diabetic Retinopathy. Diabetes care 41 (11) (2018)
Victoria Rotshild, Laurent Azoulay, Majd Zarifeh, Reem Masarwa, Bruria Hirsh Raccah, Amichai Perlman, Mordechai Muszkat, Ilan Matok
The Risk for Lung Cancer Incidence with Calcium Channel Blockers: A Systematic Review and Meta-Analysis of Observational Studies. Drug safety 41 (6) (2018)
Antonios Douros, Hui Yin, Oriana Hoi Yun Yu, Kristian B Filion, Laurent Azoulay, Samy Suissa
Pharmacologic Differences of Sulfonylureas and the Risk of Adverse Cardiovascular and Hypoglycemic Events. Diabetes care 40 (11) (2017)